
Core Viewpoint - Genpact Limited (G) is a strong stock with significant price appreciation and robust fundamentals, making it a compelling addition to investment portfolios [1] Price Performance - Genpact's stock has appreciated by 38% over the past year, outperforming the industry average of 32% and the Zacks S&P 500 composite's rise of 31.7% [2] Investment Ratings - The company holds a Zacks Rank of 2 (Buy) and a VGM Score of B, indicating strong investment potential [3] Earnings Estimates - Six estimates for 2024 have been revised upward in the last 30 days, with no downward revisions, reflecting analyst confidence. The Zacks Consensus Estimate for 2024 earnings increased by 2.2% [4] Earnings Performance - Genpact has consistently outperformed earnings estimates, achieving a positive average earnings surprise of 7.8% over the last four quarters [4] Growth Projections - The Zacks Consensus Estimate for 2024 earnings is 225.4 million in 2023 and dividends of $100 million, indicating commitment to shareholder value [8] Financial Health - As of the end of Q3 2024, Genpact's current ratio was 1.85, significantly higher than the industry average of 1.08, suggesting strong short-term financial health [9]